000 01486 a2200421 4500
005 20250513211921.0
264 0 _c20000608
008 200006s 0 0 eng d
022 _a0041-1337
024 7 _a10.1097/00007890-200005150-00032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Etten, E
245 0 0 _aAnalogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants.
_h[electronic resource]
260 _bTransplantation
_cMay 2000
300 _a1932-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBone and Bones
_xmetabolism
650 0 4 _aCalcitriol
_xanalogs & derivatives
650 0 4 _aCalcium
_xphysiology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Synergism
650 0 4 _aEncephalomyelitis, Autoimmune, Experimental
_xprevention & control
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xpharmacology
650 0 4 _aInterleukin-2
_xbiosynthesis
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMice
650 0 4 _aPhytohemagglutinins
_xpharmacology
700 1 _aBranisteanu, D D
700 1 _aVerstuyf, A
700 1 _aWaer, M
700 1 _aBouillon, R
700 1 _aMathieu, C
773 0 _tTransplantation
_gvol. 69
_gno. 9
_gp. 1932-42
856 4 0 _uhttps://doi.org/10.1097/00007890-200005150-00032
_zAvailable from publisher's website
999 _c10781771
_d10781771